Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder

Brain(2025)10.1093/brain/awaf003Source: DataRank Database

Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder is a research paper published in Brain (2025). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 18.62)OA: hybridTopics (75)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Amélie Pelletier ORCID,Emma N. Somerville ORCID,Jacques Montplaisir ORCID,Jean‐François Gagnon ORCID,Gwendlyn Kollmorgen

Live enrichment

PubMed:39761530 PMC:PMC12129744 OpenAlex:https://openalex.org/W4406109428

Canadian Institutes of Health Research

Grant: unidentified

unidentified

NIH

Canadian Consortium on Neurodegeneration in Aging

Canadian Institutes of Health Research

Michael J. Fox Foundation

Fonds de la Recherche en Sante

Canada First Research Excellence Fund

CIHR

F. Hoffmann-La Roche Ltd

HBHL

Healthy Brains for Healthy Lives initiative

FWCI

18.62

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awaf003/61356754/awaf003.pdf

publisherhttps://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awaf003/61356754/awaf003.pdf

publisherhttps://academic.oup.com/brain/article-pdf/148/6/2049/61356754/awaf003.pdf

journalhttps://doi.org/10.1093/brain/awaf003

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39761530

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsSleep and Wakefulness ResearchRestless Legs Syndrome Research03 medical and health sciences0302 clinical medicine

MeSH Terms

AgedAged, 80 and overDementiaFemaleHumansLongitudinal StudiesMaleMiddle AgedPeptide FragmentsProspective StudiesCohort StudiesBiomarkersAmyloid beta-Peptidestau ProteinsPolysomnographyDisease ProgressionREM Sleep Behavior DisorderLewy Body Disease

Keywords

DementiaREM sleep behavior disorderMedicineAmyloid (mycology)Sleep (system call)PsychologyNeurosciencePolysomnographyInternal medicinePathologyDiseaseElectroencephalographyDementia With Lewy BodiesAβ42Blood MarkersPtau181Idiopathic/isolated Rem Sleep Behaviour DisorderMaleLewy Body DiseaseClinical Neurologytau ProteinsDIAGNOSISCohort StudiesTOOLHumansLongitudinal StudiesProspective Studies11 Medical and Health SciencesPARKINSONSAgedRISKAged, 80 and overScience & TechnologyA beta 42Neurology & Neurosurgery42 Health sciencesAmyloid beta-PeptidesNeurosciences32 Biomedical and clinical sciencesMiddle AgedLEWY BODIESPeptide Fragments17 Psychology and Cognitive SciencesALZHEIMERS-DISEASE52 PsychologyCOGNITIVE DECLINEDisease ProgressionOriginal ArticleFemaleNeurosciences & NeurologyLife Sciences & BiomedicineBiomarkers